Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.
Lamarca, Angela Palmer, Daniel H Wasan, Harpreet Singh Ross, Paul J Ma, Yuk Ting Arora, Arvind Falk, Stephen Gillmore, Roopinder Wadsley, Jonathan Patel, Kinnari
Lamarca, Angela
Palmer, Daniel H
Wasan, Harpreet Singh
Ross, Paul J
Ma, Yuk Ting
Arora, Arvind
Falk, Stephen
Gillmore, Roopinder
Wadsley, Jonathan
Patel, Kinnari
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2021-07
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available
Citation
Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, Falk S, Gillmore R, Wadsley J, Patel K, Anthoney A, Maraveyas A, Iveson T, Waters JS, Hobbs C, Barber S, Ryder WD, Ramage J, Davies LM, Bridgewater JA, Valle JW; Advanced Biliary Cancer Working Group. Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply. Lancet Oncol. 2021 Jul;22(7):e288-e289. doi: 10.1016/S1470-2045(21)00341-7
Type
Other